1. Home
  2. CTNM vs CODI Comparison

CTNM vs CODI Comparison

Compare CTNM & CODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Contineum Therapeutics Inc.

CTNM

Contineum Therapeutics Inc.

HOLD

Current Price

$13.86

Market Cap

480.5M

Sector

N/A

ML Signal

HOLD

Logo D/B/A Compass Diversified Holdings Shares of Beneficial Interest

CODI

D/B/A Compass Diversified Holdings Shares of Beneficial Interest

HOLD

Current Price

$12.15

Market Cap

480.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTNM
CODI
Founded
2009
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
480.5M
480.8M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
CTNM
CODI
Price
$13.86
$12.15
Analyst Decision
Buy
Hold
Analyst Count
4
2
Target Price
$19.00
$9.25
AVG Volume (30 Days)
271.4K
955.4K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
0.46
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.35
$4.58
52 Week High
$16.33
$12.64

Technical Indicators

Market Signals
Indicator
CTNM
CODI
Relative Strength Index (RSI) 52.79 70.88
Support Level $11.62 $6.23
Resistance Level $14.63 N/A
Average True Range (ATR) 0.93 0.58
MACD 0.17 -0.08
Stochastic Oscillator 51.87 79.05

Price Performance

Historical Comparison
CTNM
CODI

About CTNM Contineum Therapeutics Inc.

Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.

About CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest

Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.

Share on Social Networks: